vs
Digimarc CORP（DMRC）与MYOMO, INC.（MYO）财务数据对比。点击上方公司名可切换其他公司
MYOMO, INC.的季度营收约是Digimarc CORP的1.3倍（$11.4M vs $8.9M），MYOMO, INC.净利率更高（-33.6% vs -47.2%，领先13.6%），Digimarc CORP同比增速更快（2.9% vs -5.9%），Digimarc CORP自由现金流更多（$895.0K vs $-2.4M），过去两年MYOMO, INC.的营收复合增速更高（73.9% vs -5.3%）
迪吉马克公司是一家企业软件与服务提供商，其主打产品包含带数字标识符的软件，主要用于解决防伪问题、验证产品真伪、提升回收准确性以及实现供应链可追溯，产品可广泛应用于服装、快消品、美妆健康、汽车等多个行业领域。
MYOMO INC.是一家医疗科技企业，研发和生产可穿戴肌电矫形设备，帮助上肢瘫痪或无力的患者恢复肢体活动能力，核心产品面向中风、脊髓损伤及其他神经系统疾病患者，主要市场覆盖北美地区。
DMRC vs MYO — 直观对比
营收规模更大
MYO
是对方的1.3倍
$8.9M
营收增速更快
DMRC
高出8.8%
-5.9%
净利率更高
MYO
高出13.6%
-47.2%
自由现金流更多
DMRC
多$3.3M
$-2.4M
两年增速更快
MYO
近两年复合增速
-5.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $8.9M | $11.4M |
| 净利润 | $-4.2M | $-3.8M |
| 毛利率 | 63.5% | 68.6% |
| 营业利润率 | -48.2% | -24.4% |
| 净利率 | -47.2% | -33.6% |
| 营收同比 | 2.9% | -5.9% |
| 净利润同比 | 51.4% | -1366.4% |
| 每股收益（稀释后） | $-0.18 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DMRCMYO
| Q4 25 | $8.9M | $11.4M | ||
| Q3 25 | $7.6M | $10.1M | ||
| Q2 25 | $8.0M | $9.7M | ||
| Q1 25 | $9.4M | $9.8M | ||
| Q4 24 | $8.7M | $12.1M | ||
| Q3 24 | $9.4M | $9.2M | ||
| Q2 24 | $10.4M | $7.5M | ||
| Q1 24 | $9.9M | $3.8M |
净利润DMRCMYO
| Q4 25 | $-4.2M | $-3.8M | ||
| Q3 25 | $-8.2M | $-3.7M | ||
| Q2 25 | $-8.2M | $-4.6M | ||
| Q1 25 | $-11.7M | $-3.5M | ||
| Q4 24 | $-8.6M | $-260.1K | ||
| Q3 24 | $-10.8M | $-966.4K | ||
| Q2 24 | $-9.3M | $-1.1M | ||
| Q1 24 | $-10.3M | $-3.8M |
毛利率DMRCMYO
| Q4 25 | 63.5% | 68.6% | ||
| Q3 25 | 58.3% | 63.8% | ||
| Q2 25 | 58.8% | 62.7% | ||
| Q1 25 | 65.0% | 67.2% | ||
| Q4 24 | 60.8% | 71.4% | ||
| Q3 24 | 62.4% | 75.4% | ||
| Q2 24 | 66.1% | 70.8% | ||
| Q1 24 | 62.5% | 61.2% |
营业利润率DMRCMYO
| Q4 25 | -48.2% | -24.4% | ||
| Q3 25 | -109.7% | -34.9% | ||
| Q2 25 | -105.2% | -47.6% | ||
| Q1 25 | -128.9% | -35.8% | ||
| Q4 24 | -105.1% | -2.0% | ||
| Q3 24 | -120.4% | -10.4% | ||
| Q2 24 | -96.2% | -14.8% | ||
| Q1 24 | -109.2% | -103.6% |
净利率DMRCMYO
| Q4 25 | -47.2% | -33.6% | ||
| Q3 25 | -106.9% | -36.3% | ||
| Q2 25 | -102.6% | -48.0% | ||
| Q1 25 | -125.2% | -35.2% | ||
| Q4 24 | -99.9% | -2.2% | ||
| Q3 24 | -113.9% | -10.5% | ||
| Q2 24 | -89.3% | -14.9% | ||
| Q1 24 | -104.0% | -102.2% |
每股收益（稀释后）DMRCMYO
| Q4 25 | $-0.18 | $-0.09 | ||
| Q3 25 | $-0.38 | $-0.09 | ||
| Q2 25 | $-0.38 | $-0.11 | ||
| Q1 25 | $-0.55 | $-0.08 | ||
| Q4 24 | $-0.40 | $0.00 | ||
| Q3 24 | $-0.50 | $-0.03 | ||
| Q2 24 | $-0.43 | $-0.03 | ||
| Q1 24 | $-0.50 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $12.9M | $18.4M |
| 总债务越低越好 | — | $11.2M |
| 股东权益账面价值 | $40.2M | $11.4M |
| 总资产 | $53.0M | $38.6M |
| 负债/权益比越低杠杆越低 | — | 0.98× |
8季度趋势，按日历期对齐
现金及短期投资DMRCMYO
| Q4 25 | $12.9M | $18.4M | ||
| Q3 25 | $12.6M | $12.6M | ||
| Q2 25 | $16.1M | $15.5M | ||
| Q1 25 | $21.6M | $21.5M | ||
| Q4 24 | $28.7M | $24.9M | ||
| Q3 24 | $33.7M | $6.6M | ||
| Q2 24 | $41.5M | $9.0M | ||
| Q1 24 | $48.9M | $11.0M |
总债务DMRCMYO
| Q4 25 | — | $11.2M | ||
| Q3 25 | — | $2.4M | ||
| Q2 25 | — | $1.3M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益DMRCMYO
| Q4 25 | $40.2M | $11.4M | ||
| Q3 25 | $41.4M | $14.6M | ||
| Q2 25 | $46.5M | $17.6M | ||
| Q1 25 | $50.0M | $21.7M | ||
| Q4 24 | $61.4M | $24.7M | ||
| Q3 24 | $70.2M | $9.3M | ||
| Q2 24 | $77.2M | $9.7M | ||
| Q1 24 | $84.5M | $10.9M |
总资产DMRCMYO
| Q4 25 | $53.0M | $38.6M | ||
| Q3 25 | $55.4M | $34.1M | ||
| Q2 25 | $60.7M | $38.7M | ||
| Q1 25 | $66.5M | $40.9M | ||
| Q4 24 | $75.8M | $42.2M | ||
| Q3 24 | $85.0M | $16.3M | ||
| Q2 24 | $93.4M | $16.2M | ||
| Q1 24 | $99.7M | $16.5M |
负债/权益比DMRCMYO
| Q4 25 | — | 0.98× | ||
| Q3 25 | — | 0.17× | ||
| Q2 25 | — | 0.08× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $991.0K | $-1.1M |
| 自由现金流经营现金流 - 资本支出 | $895.0K | $-2.4M |
| 自由现金流率自由现金流/营收 | 10.0% | -21.0% |
| 资本支出强度资本支出/营收 | 1.1% | 10.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-12.3M | $-18.7M |
8季度趋势，按日历期对齐
经营现金流DMRCMYO
| Q4 25 | $991.0K | $-1.1M | ||
| Q3 25 | $-2.6M | $-1.8M | ||
| Q2 25 | $-4.7M | $-8.9M | ||
| Q1 25 | $-5.5M | $-2.7M | ||
| Q4 24 | $-4.2M | $3.4M | ||
| Q3 24 | $-7.1M | $-1.5M | ||
| Q2 24 | $-6.8M | $-1.9M | ||
| Q1 24 | $-8.4M | $-3.2M |
自由现金流DMRCMYO
| Q4 25 | $895.0K | $-2.4M | ||
| Q3 25 | $-2.8M | $-2.9M | ||
| Q2 25 | $-4.9M | $-10.1M | ||
| Q1 25 | $-5.5M | $-3.3M | ||
| Q4 24 | $-4.2M | $2.5M | ||
| Q3 24 | $-7.2M | $-1.8M | ||
| Q2 24 | $-6.9M | $-2.0M | ||
| Q1 24 | $-8.5M | $-3.3M |
自由现金流率DMRCMYO
| Q4 25 | 10.0% | -21.0% | ||
| Q3 25 | -36.9% | -28.6% | ||
| Q2 25 | -61.0% | -104.9% | ||
| Q1 25 | -59.1% | -34.0% | ||
| Q4 24 | -49.1% | 20.8% | ||
| Q3 24 | -75.7% | -19.7% | ||
| Q2 24 | -66.1% | -27.1% | ||
| Q1 24 | -85.8% | -88.0% |
资本支出强度DMRCMYO
| Q4 25 | 1.1% | 10.9% | ||
| Q3 25 | 2.9% | 10.4% | ||
| Q2 25 | 2.5% | 13.0% | ||
| Q1 25 | 0.6% | 6.8% | ||
| Q4 24 | 0.2% | 7.1% | ||
| Q3 24 | 0.7% | 3.5% | ||
| Q2 24 | 0.3% | 1.6% | ||
| Q1 24 | 1.1% | 1.6% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DMRC
| Subscription | $5.3M | 60% |
| The Government | $3.6M | 41% |
MYO
| Direct To Patient | $7.9M | 69% |
| Clinical And Medical Providers | $3.5M | 31% |
